CHAPEL HILL, N.C., June 3 /PRNewswire/ -- Market competition is mounting to win the time, attention and interest of the most qualified clinical investigators. Field research shows that the most sought-after clinical investigation sites turn down 60-70% of the clinical trial invitations that they receive at their labs and clinics. Consequently, leading pharmaceutical companies are seeking better ways to manage the art and science of investigator recruitment.
The toolkit recently released by Best Practices, LLC, accessible at http://www3.best-in-class.com/rr954.htm, integrates best practices in winning clinical investigators in a competitive marketplace into a straightforward format. Best Practices, LLC CEO, Chris Bogan, stated, "Recruiting top clinical investigators is extremely important to the clinical trials process and in today's competitive environment, this toolkit has provided key insights and a process accessed repeatedly by our clients, providing continuing value over time."
This toolkit is designed to aid managers in their efforts to identify, select and recruit top investigators in their therapeutic areas. The toolkit draws from interviews and surveys of executives at 15 pharmaceutical companies and 7 Contract Research Organizations/Site Management Organizations. It also includes insights gathered from interviews and surveys with a cross section of 20 investigators and investigative site staff members. Some of the influential companies that contributed to the toolkit include: Amgen, AstraZeneca, Baxter, BMS, Lilly, GSK and Roche among others.
To download a complimentary summary or to access the full toolkit, "Clinical Trial Excellence: Toolkit for Winning Investigators in a Competitive Marketplace," visit http://www3.best-in-class.com/rr954.htm.
For more information on this report, contac
|SOURCE Best Practices, LLC|
Copyright©2008 PR Newswire.
All rights reserved